Thymidine kinase 1 and thymidine phosphorylase expression in non-small-cell lung carcinoma in relation to angiogenesis and proliferation

Journal of Histochemistry and Cytochemistry

Volumn 57, Issue 11, 2009, Pages 1087-1097

  Brockenbrough, J Scott ^a   Morihara, Janice K ^b   Hawes, Stephen E ^b   Stern, Joshua E ^b   Rasey, Janet S ^b   Wiens, Linda W ^a   Feng, Qinghua ^b   Vesselle, Hubert ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; NSCLC; Proliferation; Thymidine kinase 1; Thymidine phosphorylase

Indexed keywords

CD31 ANTIGEN; KI 67 ANTIGEN; THYMIDINE; THYMIDINE KINASE 1; THYMIDINE PHOSPHORYLASE; THYMIDINE KINASE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD VESSEL; CANCER PATIENT; CELL NUCLEUS; CELL PROLIFERATION; CYTOPLASM; DIAGNOSTIC IMAGING; FEMALE; HUMAN; HUMAN TISSUE; IMAGING; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METABOLISM; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STAINING; TISSUE DISTRIBUTION; TUMOR CELL; TUMOR VOLUME; CLINICAL TRIAL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULARIZATION;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL NUCLEUS; CELL PROLIFERATION; CLINICAL TRIALS AS TOPIC; CYTOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; STAINING AND LABELING; THYMIDINE KINASE; THYMIDINE PHOSPHORYLASE; TUMOR BURDEN;

EID: 70449732675     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.2009.952804     Document Type: Article

References (91)

1. Aikawa H, Takahashi H, Fujimura S, Sato M, Endo C, Sakurada A, Kondo T, et al. (1999) Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer. Anticancer Res 19:4305-4309
2. Brown NS, Bicknell R (1998) Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. Biochem J 334:1-8
3. Chalkley H (1943) Method for the quantitative morphological analysis of tissues. J Natl Cancer Inst 4:47-53
4. Chujo M, Miura T, Kawano Y, Miyawaki M, Imakiire T, Hayashita Y, Kawahara K (2006) Thymidine phosphorylase levels and dihydropyrimidine dehydrogenase levels in non-small cell lung cancer tissues. Oncol Rep 16:777-780
5. Cotter TG, Lennon SV, Glynn JG, Martin SJ (1990) Cell death via apoptosis and its relationship to growth, development and differentiation of both tumour and normal cells. Anticancer Res 10:1153-1159
6. Cui JQ, Shi YF, Zhou HJ, Li JQ (2004) The changes of gene expression profiles in hydatidiform mole and choriocarcinoma with hyperplasia of trophoblasts. Int J Gynecol Cancer 14:984-997
7. de Bruin M, Smid K, Laan AC, Noordhuis P, Fukushima M, Hoekman K, Pinedo HM, et al. (2003) Rapid disappearance of deoxyribose-1-phosphate in platelet derived endothelial cell growth factor/thymidine phosphorylase overexpressing cells. Biochem Biophys Res Commun 301:675-679
8. Dunnill MS, Gatter KC (1986) Cellular heterogeneity in lung cancer. Histopathology 10:461-475
9. Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG (2000) Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 60:1388-1393
10. Folkman J (2003) Fundamental concepts of the angiogenic process. Curr Mol Med 3:643-651
11. Fox SB, Leek RD, Smith K, Hollyer J, Greenall M, Harris AL (1994) Tumor angiogenesis in node-negative breast carcinomas: relationship with epidermal growth factor receptor, estrogen receptor, and survival. Breast Cancer Res Treat 29:109-116
12. Fox SB, Leek RD, Smith K, Hollyer J, Greenall M, Harris AL (1995a) Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 177:275-283
13. Fox SB, Moghaddam A, Westwood M, Turley H, Bicknell R, Gatter KC, Harris AL (1995b) Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J Pathol 176:183-190
14. Fujiwaki R, Hata K, Moriyama M, Iwanari O, Katabuchi H, Okamura H, Miyazaki K (2001) Clinical value of thymidine kinase in patients with cervical carcinoma. Oncology 61:47-54
15. Gatter KC, Dunnill MS, Pulford KA, Heryet A, Mason DY (1985) Human lung tumours: a correlation of antigenic profile with histological type. Histopathology 9:805-823
16. Giatromanolaki A, Sivridis E, Simopoulos C, Polychronidis A, Gatter KC, Harris AL, Koukourakis MI (2002) Thymidine phosphorylase expression in gallbladder adenocarcinomas. Int J Surg Pathol 10:181-188
17. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379:88-91
18. Grierson JR, Brockenbrough JS, Rasey JS, Wiens LW, Schwartz JL, Jordan R, Vesselle H (2007) Evaluation of 5′-deoxy-5′-[F-18] fluorothymidine as a tracer of intracellular thymidine phosphorylase activity. Nucl Med Biol 34:471-478
19. Grierson JR, Shields AF (2000) Radiosynthesis of 3′-deoxy-3′- [(18) F]fluorothymidine: [(18)F]FLT for imaging of cellular proliferation in vivo. Nucl Med Biol 27:143-156
20. Haraguchi M, Miyadera K, Uemura K, Sumizawa T, Furukawa T, Yamada K, Akiyama S, et al. (1994) Angiogenic activity of enzymes. Nature 368:198
21. Hengstschlager M, Knofler M, Mullner EW, Ogris E, Wintersberger E, Wawra E (1994a) Different regulation of thymidine kinase during the cell cycle of normal versus DNA tumor virus-transformed cells. J Biol Chem 269:13836-13842
22. Hengstschlager M, Mudrak I, Wintersberger E, Wawra E (1994b) A common regulation of genes encoding enzymes of the deoxy-nucleotide metabolism is lost after neoplastic transformation. Cell Growth Differ 5:1389-1394
23. Hirano Y, Takayama T, Kageyama S, Ushiyama T, Suzuki K, Fujita K (2003) Thymidine phosphorylase and dihydropyrimidine dehydrogenase in renal cell carcinoma: relationship between histological parameters and chemosensitivity to 5-fluorouracil. Eur Urol 43:45-51
24. Hirsch FR, Ottesen G, Pødenphant J, Olsen J (1983) Tumor heterogeneity in lung cancer based on light microscopic features. A retrospective study of a consecutive series of 200 patients, treated surgically. Virchows Arch A Pathol Anat Histopathol 402:147-153
25. Hlatky L, Hahnfeldt P, Folkman J (2002) Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst 94:883-893
26. Hotchkiss KA, Ashton AW, Klein RS, Lenzi ML, Zhu GH, Schwartz EL (2003) Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration. Cancer Res 63:527-533
27. Hu CM, Chang ZF (2007) Mitotic control of dTTP pool: a necessity or coincidence? J Biomed Sci 14:491-497
28. Ikeda R, Che XF, Ushiyama M, Yamaguchi T, Okumura H, Nakajima Y, Takeda Y, et al. (2006) 2-Deoxy-D-ribose inhibits hypoxia-induced apoptosis by suppressing the phosphorylation of p38 MAPK. Biochem Biophys Res Commun 342:280-285
29. Ikeda R, Furukawa T, Kitazono M, Ishitsuka K, Okumura H, Tani A, Sumizawa T, et al. (2002) Molecular basis for the inhibition of hypoxia-induced apoptosis by 2-deoxy-ribose. Biochem Biophys Res Commun 291:806-812
30. Ikeguchi M, Oka S, Saito H, Kondo A, Tsujitani S, Maeta M, Kaibara N (1999) Clinical significance of the detection of thymidine phosphorylase activity in esophageal squamous cell carcinomas. Eur Surg Res 31:357-363
31. Johansson M, Brismar S, Karlsson A (1997) Human deoxycytidine kinase is located in the cell nucleus. Proc Natl Acad Sci USA 94:11941-11945
32. Ke PY, Kuo YY, Hu CM, Chang ZF (2005) Control of dTTP pool size by anaphase promoting complex/cyclosome is essential for the maintenance of genetic stability. Genes Dev 19:1920-1933
33. Key G, Becker MH, Baron B, Duchrow M, Schlüter C, Flad HD, Gerdes J (1993) New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 68:629-636
34. Kim JW, Dang CV (2006) Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 66:8927-8930
35. Klecker RW Jr, Collins JM (2001) Thymidine phosphorylase as a target for imaging and therapy with thymine analogs. Cancer Chemother Pharmacol 48:407-412
36. Koide N, Watanabe H, Yazawa K, Adachi W, Amano J (1999) Immunohistochemical expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in squamous cell carcinoma of the esophagus. Hepatogastroenterology 46:944-951
37. Kong XB, Zhu QY, Vidal PM, Watanabe KA, Polsky B, Armstrong D, Ostrander M, et al. (1992) Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3′-fluoro-3′-deoxythymidine and 3′-azido-3′- deoxythymidine. Antimicrob Agents Chemother 36:808-818
38. Koukourakis MI, Giatromanolaki A, Fountzilas G, Sivridis E, Gatter KC, Harris AL (2000) Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy. Clin Cancer Res 6:381-389
39. Koukourakis MI, Giatromanolaki A, Kakolyris S, O'Byrne KJ, Apostolikas N, Skarlatos J, Gatter KC, et al. (1998) Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival. Br J Cancer 77:1696-1703
40. Koukourakis MI, Giatromanolaki A, O'Byrne KJ, Comley M, Whitehouse RM, Talbot DC, Gatter KC, et al. (1997) Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer. Br J Cancer 75:477-481
41. Kuroiwa N, Nakayama M, Fukuda T, Fukui H, Ohwada H, Hiwasa T, Fujimura S (2001) Specific recognition of cytosolic thymidine kinase in the human lung tumor by monoclonal antibodies raised against recombinant human thymidine kinase. J Immunol Methods 253:1-11
42. Landry J, Freyer JP, Sutherland RM (1981) Shedding of mitotic cells from the surface of multicell spheroids during growth. J Cell Physiol 106:23-32
43. Li C, Shintani S, Terakado N, Klosek SK, Ishikawa T, Nakashiro K, Hamakawa H (2005) Microvessel density and expression of vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived endothelial growth factor in oral squamous cell carcinomas. Int J Oral Maxillofac Surg 34:559-565
44. Liekens S, Bronckaers A, Pérez-Pérez MJ, Balzarini J (2007) Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy. Biochem Pharmacol 74:1555-1567
45. Maehara Y, Moriguchi S, Emi Y, Watanabe A, Kohnoe S, Tsujitani S, Sugimachi K (1990) Comparison of pyrimidine nucleotide synthetic enzymes involved in 5-fluorouracil metabolism between human adenocarcinomas and squamous cell carcinomas. Cancer 66:156-161
46. Mao Y, Wu J, Skog S, Eriksson S, Zhao Y, Zhou J, He Q (2005) Expression of cell proliferating genes in patients with non-small cell lung cancer by immunohistochemistry and cDNA profiling. Oncol Rep 13:837-846.
47. Mao Y, Wu J, Wang N, He L, Wu C, He Q, Skog S (2002) A comparative study: immunohistochemical detection of cytosolic thymidine kinase and proliferating cell nuclear antigen in breast cancer. Cancer Invest 20:922-931
48. Matsuura T, Kuratate I, Teramachi K, Osaki M, Fukuda Y, Ito H (1999) Thymidine phosphorylase expression is associated with both increase of intratumoral microvessels and decrease of apoptosis in human colorectal carcinomas. Cancer Res 59:5037-5040
49. McClelland MR, Carskadon SL, Zhao L, White ES, Beer DG, Orringer MB, Pickens A, et al. (2007) Diversity of the angiogenic phenotype in non-small cell lung cancer. Am J Respir Cell Mol Biol 36:343-350
50. Mikulits W, Hengstschläger M, Sauer T, Wintersberger E, Müllner EW (1996) Overexpression of thymidine kinase mRNA eliminates cell cycle regulation of thymidine kinase enzyme activity. J Biol Chem 271:853-860
51. Miyake K, Imura S, Yoshizumi T, Ikemoto T, Morine Y, Shimada M (2007) Role of thymidine phosphorylase and orotate phosphoribosyltransferase mRNA expression and its ratio to dihydropyrimidine dehydrogenase in the prognosis and clinicopathological features of patients with pancreatic cancer. Int J Clin Oncol 12:111-119
52. Mizukami Y, Jo WS, Duerr EM, Gala M, Li J, Zhang X, Zimmer MA, et al. (2005) Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells. Nat Med 11:992-997
53. Moghaddam A, Zhang HT, Fan TP, Hu DE, Lees VC, Turley H, Fox SB, et al. (1995) Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA 92:998-1002
54. Morita T, Matsuzaki A, Tokue A (2003) Quantitative analysis of thymidine phosphorylase and dihydropyrimidine dehydrogenase in renal cell carcinoma. Oncology 65:125-131
55. Noguchi H, Prem veer Reddy G, Pardee AB (1983) Rapid incorporation of label from ribonucleoside disphosphates into DNA by a cell-free high molecular weight fraction from animal cell nuclei. Cell 32:443-451
56. O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL (1995) Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res 55:510-513
57. O'Brien TS, Fox SB, Dickinson AJ, Turley H, Westwood M, Moghaddam A, Gatter KC, et al. (1996) Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res 56:4799-4804
58. O'Byrne KJ, Koukourakis MI, Giatromanolaki A, Cox G, Turley H, Steward WP, Gatter K, et al. (2000) Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer. Br J Cancer 82:1427-1432
59. Oudard S, Levalois C, Andrieu JM, Bougaran J, Validire P, Thiounn N, Poupon MF, et al. (2002) Expression of genes involved in chemoresistance, proliferation and apoptosis in clinical samples of renal cell carcinoma and correlation with clinical outcome. Anticancer Res 22:121-128
60. Overholtzer M, Mailleux AA, Mouneimne G, Normand G, Schnitt SJ, King RW, Cibas ES, et al. (2007) A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell 131:966-979
61. Parums DV, Cordell JL, Micklem K, Heryet AR, Gatter KC, Mason DY (1990) JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol 43:752-757
62. Passantino L, Patruno R, Valerio P, Penna A, Mazzone F, Zito AF, Catalano V, et al. (2005) Thymidine phosphorylase profiles in nonmalignant and malignant pancreatic tissue. Potential therapeutic role of capecitabine on tumoral and endothelial cells and tumor-infiltrating macrophages. Immunopharmacol Immunotoxicol 27:95-107
63. Petersen I, Petersen S (2001) Towards a genetic-based classification of human lung cancer. Anal Cell Pathol 22:111-121
64. Pezzella F, Pastorino U, Tagliabue E, Andreola S, Sozzi G, Gasparini G, Menard S, et al. (1997) Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol 151:1417-1423
65. Plucinski TM, Fager RS, Reddy GP (1990) Allosteric interaction of components of the replitase complex is responsible for enzyme cross-inhibition. Mol Pharmacol 38:114-120
66. Rasey JS, Grierson JR, Wiens LW, Kolb PD, Schwartz JL (2002) Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. J Nucl Med 43:1210-1217
67. Sardari Nia P, Colpaert C, Vermeulen P, Weyler J, Pezzella F, Van Schil P, Van Marck E (2008) Different growth patterns of non-small cell lung cancer represent distinct biologic subtypes. Ann Thorac Surg 85:395-405
68. Sato J, Sata M, Nakamura H, Inoue S, Wada T, Takabatake N, Otake K, et al. (2003) Role of thymidine phosphorylase on invasiveness and metastasis in lung adenocarcinoma. Int J Cancer 106:863-870
69. Sherley JL, Kelly TJ (1988) Regulation of human thymidine kinase during the cell cycle. J Biol Chem 263:8350-8358
70. Shields AF, Grierson JR, Dohmen BM, Machulla HJ, Stayanoff JC, Lawhorn-Crews JM, Obradovich JE, et al. (1998) Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med 4:1334-1336
71. Shiotani T, Hashimoto Y, Fujita J, Yamauchi N, Yamaji Y, Futami H, Bungo M, et al. (1989a) Reversal of enzymic phenotype of thymidine metabolism in induced differentiation of U-937 cells. Cancer Res 49:6758-6763
72. Shiotani T, Hashimoto Y, Tanaka T, Irino S (1989b) Behavior of activities of thymidine metabolizing enzymes in human leukemialymphoma cells. Cancer Res 49:1090-1094
73. Stavropoulos NE, Bouropoulos C, Ioachim E, Michael M, Hastazeris K, Tsimaris I, Kalogeras D, et al. (2005) Prognostic significance of thymidine phosphorylase in superficial bladder carcinoma. Int Urol Nephrol 37:55-60
74. Steinberg F, Röhrborn HJ, Otto T, Scheufler KM, Streffer C (1997) NIR reflection measurements of hemoglobin and cytochrome aa3 in healthy tissue and tumors. Correlations to oxygen consumption: preclinical and clinical data. Adv Exp Med Biol 428: 69-77
75. Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T, Yamada Y, et al. (1996a) Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 88:1110-1117
76. Takebayashi Y, Yamada K, Miyadera K, Sumizawa T, Furukawa T, Kinoshita F, Aoki D, et al. (1996b) The activity and expression of thymidine phosphorylase in human solid tumours. Eur J Cancer 32A:1227-1232
77. Tu Z, Prajapati S, Park KJ, Kelly NJ, Yamamoto Y, Gaynor RB (2006) IKK alpha regulates estrogen-induced cell cycle progression by modulating E2F1 expression. J Biol Chem 281:6699-6706
78. Uchimiya H, Furukawa T, Okamoto M, Nakajima Y, Matsushita S, Ikeda R, Gotanda T, et al. (2002) Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose. Cancer Res 62:2834-2839
79. veer Reddy GP, Pardee AB (1980) Multienzyme complex for metabolic channeling in mammalian DNA replication. Proc Natl Acad Sci USA 77:3312-3316
80. veer Reddy GP, Pardee AB (1983) Inhibitor evidence for allosteric interaction in the replitase multienzyme complex. Nature 304:86-88
81. Vertongen F, Fondu P, van den Heule B, Cauchie C, Mandelbaum IM (1984) Thymidine kinase and thymidine phosphorylase activities in various types of leukaemia and lymphoma. Tumour Biol 5:303-311
82. Vesselle H, Freeman JD, Wiens L, Stern J, Nguyen HQ, Hawes SE, Bastian P, et al. (2007) Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role. Clin Cancer Res 13:255-263
83. Vesselle H, Grierson J, Muzi M, Pugsley JM, Schmidt RA, Rabinowitz P, Peterson LM, et al. (2002) In vivo validation of 3′deoxy-3′-[(18)F] fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors. Clin Cancer Res 8:3315-3323
84. Vesselle H, Turcotte E, Wiens L, Schmidt R, Takasugi JE, Lalani T, Vallières E, et al. (2004) Relationship between non-small cell lung cancer fluorodeoxyglucose uptake at positron emission tomography and surgical stage with relevance to patient prognosis. Clin Cancer Res 10:4709-4716
85. Volm M, Mattern J, Koomagi R (1998) Expression of platelet-derived endothelial cell growth factor in non-small cell lung carcinomas: relationship to various biological factors. Int J Oncol 13:975-979
86. Weinberg G, Ullman B, Martin DW Jr (1981) Mutator phenotypes in mammalian cell mutants with distinct biochemical defects and abnormal deoxyribonucleoside triphosphate pools. Proc Natl Acad Sci USA 78:2447-2451
87. Willis RA (1948) Epithelial tumours of the trachea, bronchi and lung. In Pathology of Tumors. Butterworth, London
88. Wu J, Mao Y, He L, Wang N, Wu C, He Q, Skog S (2000) A new cell proliferating marker: cytosolic thymidine kinase as compared to proliferating cell nuclear antigen in patients with colorectal carcinoma. Anticancer Res 20:4815-4820
89. Yasuno M, Mori T, Koike M, Takahashi K, Toi M, Takizawa T, Shimizu S, et al. (2005) Importance of thymidine phosphorylase expression in tumor stroma as a prognostic factor in patients with advanced colorectal carcinoma. Oncol Rep 13:405-412
90. Yoshioka A, Tanaka S, Hiraoka O, Koyama Y, Hirota Y, Ayusawa D, Seno T, et al. (1987) Deoxyribonucleoside triphosphate imbalance. 5-Fluorodeoxyuridine- induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death. J Biol Chem 262:8235-8241
91. Yusa T, Yamaguchi Y, Ohwada H, Hayashi Y, Kuroiwa N, Morita T, Asanagi M, et al. (1988) Activity of the cytosolic isozyme of thymidine kinase in human primary lung tumors with reference to malignancy. Cancer Res 48:5001-5006